We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUD
3001
DELISTED
Hudson Ltd. Class A Common Shares
HUD
$3K ﹤0.01%
189
-536
-74% -$6.99K
FHK
3002
DELISTED
First Trust Hong Kong AlphaDEX Fund
FHK
$3K ﹤0.01%
82
-50
-38% -$1.67K
FSB
3003
DELISTED
Franklin Financial Network, Inc.
FSB
$3K ﹤0.01%
89
-2,789
-97% -$91.8K
NTGN
3004
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$3K ﹤0.01%
2,515
-11,856
-82% -$18.9K
THCAU
3005
DELISTED
Tuscan Holdings Corp. II Unit
THCAU
$3K ﹤0.01%
319
-80
-20% -$807
PSXP
3006
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$3K ﹤0.01%
41
-3,664
-99% -$207K
MBT
3007
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$3K ﹤0.01%
340
-10,120
-97% -$92.6K
SVA
3008
DELISTED
Sinovac Biotech, Ltd
SVA
$3K ﹤0.01%
+424
New +$3K
DOC
3009
DELISTED
PHYSICIANS REALTY TRUST
DOC
$3K ﹤0.01%
184
-1,704
-90% -$31.3K
AEF
3010
abrdn Emerging Markets Equity Income Fund
AEF
$364M
$2K ﹤0.01%
292
AEHR icon
3011
Aehr Test Systems
AEHR
$3.46B
$2K ﹤0.01%
1,032
+902
+694% +$1.69K
AGX icon
3012
Argan
AGX
$8.15B
$2K ﹤0.01%
53
+19
+56% +$730
ALLT icon
3013
Allot
ALLT
$369M
$2K ﹤0.01%
+275
New +$2.25K
AMC icon
3014
AMC Entertainment Holdings
AMC
$2.16B
$2K ﹤0.01%
29
-343
-92% -$30.2K
ARCC icon
3015
Ares Capital
ARCC
$14.3B
$2K ﹤0.01%
89
-6,602
-99% -$123K
ARL icon
3016
American Realty Investors
ARL
$243M
$2K ﹤0.01%
99
-257
-72% -$3.83K
AVTX icon
3017
Avalo Therapeutics
AVTX
$1.06B
0
DCH
3018
Dauch Corp
DCH
$1.58B
$2K ﹤0.01%
153
-3,086
-95% -$29.4K
AZZ icon
3019
AZZ Inc
AZZ
$4.58B
$2K ﹤0.01%
34
-519
-94% -$21.2K
BAR icon
3020
GraniteShares Gold Shares
BAR
$1.48B
$2K ﹤0.01%
+100
New +$1.48K
BJRI icon
3021
BJ's Restaurants
BJRI
$1.46B
$2K ﹤0.01%
52
-2,016
-97% -$77.3K
BOKF icon
3022
BOK Financial
BOKF
$8.7B
$2K ﹤0.01%
22
-52
-70% -$4.24K
BWFG icon
3023
Bankwell Financial Group
BWFG
$533M
$2K ﹤0.01%
75
-33
-31% -$943
CAT icon
3024
Caterpillar
CAT
$385B
$2K ﹤0.01%
14
-18,033
-100% -$2.52M
CCNE icon
3025
CNB Financial Corp
CCNE
$1.02B
$2K ﹤0.01%
55
-389
-88% -$12.2K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.